Lv1
30 积分 2025-05-29 加入
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study
15天前
已关闭
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
AHEAD-MERIT: A Phase II/III Trial of First Line (1L) BNT113 Plus Pembrolizumab in Unresectable Recurrent or Metastatic HPV16+ HNSCC
1个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
2个月前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
3个月前
已完结
Intravesical T3011, an IL-12/anti-PD-1 armed oncolytic HSV-1, in BCG-naïve high-risk NMIBC: A phase IIa trial
3个月前
已完结
Progress of phase II study of MVR-T3011, an IL-12/anti-PD-1 armed oncolytic HSV-1, in high-risk BCG-unresponsive CIS and papillary NMIBC
3个月前
已完结
Human papillomavirus vaccination coverage and willingness among women in mainland China: A meta-analysis based on the COM-B model
3个月前
已关闭
Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus
4个月前
已完结
The Systemic Lupus Erythematosus Responder Index (SRI); A new SLE disease activity assessment
4个月前
已完结
皖公网安备34019202002308
